摘要
The effective management of patients with chronic liver disease (CLD) and portal hypertension (PHT) has significantly prolonged their survival. Hence, there is an emerging number of patients who will require major elective intrabdominal surgery for reasons unrelated to their CLD (e.g., colorectal cancer).
